Longboard Pharmaceuticals Financials

Longboard Pharmaceuticals Stock Summary

Longboard Pharmaceuticals competes with Molecular Partners, MediciNova, Anebulo Pharmaceuticals, Champions Oncology, and Werewolf Therapeutics. Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California. Longboard Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people.

Longboard Pharmaceuticals Key Financial Ratios

Longboard Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Longboard Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Longboard Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Longboard Pharmaceuticals competition to find correlations between indicators driving Longboard Pharmaceuticals's intrinsic value. More Info.Longboard Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Longboard Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Longboard Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Longboard Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Longboard Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Longboard Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Longboard Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Longboard Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.